Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: other routes
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: well-documented, scientifically acceptable study report

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1980
Report date:
1980

Materials and methods

Principles of method if other than guideline:
according to BASF-internal standard
GLP compliance:
no
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Hydrogen [29H,31H-phthalocyaninesulphonato(2-)-N29,N30,N31,N32]cuprate(1-), compound with (Z)-octadec-9-enylamine (1:1)
EC Number:
288-107-0
EC Name:
Hydrogen [29H,31H-phthalocyaninesulphonato(2-)-N29,N30,N31,N32]cuprate(1-), compound with (Z)-octadec-9-enylamine (1:1)
Cas Number:
85650-96-0
Molecular formula:
C32 H15 Cu N8 O3 S .C18 H37 N .H
IUPAC Name:
Hydrogen [29H,31H-phthalocyaninesulphonato(2-)-N29,N30,N31,N32]cuprate(1-), compound with dodecylamine

Test animals

Species:
mouse
Strain:
NMRI
Sex:
male/female
Details on test animals or test system and environmental conditions:
The animals were offered a standardized animal laboratory diet. Food depreviation about 15 - 20 h before study start.

Administration / exposure

Route of administration:
intraperitoneal
Vehicle:
CMC (carboxymethyl cellulose)
Details on exposure:
0.5% aqueous carboxymethyl cellulose preparation
Form of application: suspension
Concentrations used: 2, 7 and 20% (G/V)
Application volume: 10 ml/kg
Doses:
200, 700 and 2000 mg/kg
No. of animals per sex per dose:
5
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 200 - < 700 mg/kg bw
Mortality:
200 mg/kg: no deaths after 14 days; 700 and 2000 mg/kg: 10/10 after 14 days
Clinical signs:
Dyspnea, apathy, abnormal position, staggering, tremors, spastic gait, tonic and clonic convulsions, skin blue, urine turquoise and blue, ruffled fur, exsiccosis, adhesion of eyelids, poor general state
Body weight:
Mean body weight male animals: 25.3 g at study start, 29.2 g after 13 days
Mean body weight female animals: 23.7 g at study start, 25.6 g after 13 days
Gross pathology:
Animals that died: intraabdominal precipitates of the test substance and coloration
Sacrificed animals: intraabdominal incorporations of the test substance

Applicant's summary and conclusion